 |
N-(3,4-dihydroxyphenyl)-3,4-dihydroxybenzamide |
|---|---|
| Trade Name | |
| Orphan Indication | AL Amyloidosis |
| USA Market Approval | USA |
| USA Designation Date | 2014-10-15 00:00:00 |
| Sponsor | ProtaMed, Inc.;14241 Woodinville Duvall Road, Suite # 370;Woodinville, Washington, 98072 |
